MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 59 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,184,815 | +43.9% | 1,733,757 | +19.1% | 0.01% | +50.0% |
| Q2 2023 | $37,652,362 | +12.5% | 1,455,445 | +4.5% | 0.01% | +14.3% |
| Q1 2023 | $33,458,539 | +19.4% | 1,392,945 | -3.1% | 0.01% | +16.7% |
| Q4 2022 | $28,024,601 | +41.5% | 1,437,159 | +52.4% | 0.01% | +50.0% |
| Q3 2022 | $19,808,000 | +129.0% | 942,777 | +112.1% | 0.00% | +100.0% |
| Q2 2022 | $8,649,000 | +6.0% | 444,447 | +19.9% | 0.00% | 0.0% |
| Q1 2022 | $8,163,000 | +181.1% | 370,728 | +103.7% | 0.00% | – |
| Q4 2021 | $2,904,000 | -0.5% | 182,026 | +24.3% | 0.00% | – |
| Q3 2021 | $2,919,000 | +985.1% | 146,478 | +848.9% | 0.00% | – |
| Q4 2020 | $269,000 | -48.1% | 15,437 | -42.6% | 0.00% | – |
| Q3 2020 | $518,000 | +102.3% | 26,879 | +104.6% | 0.00% | – |
| Q2 2020 | $256,000 | – | 13,137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,566,912 | $62,278,000 | 4.80% |
| RiverVest Venture Management LLC | 1,921,118 | $33,543,000 | 3.68% |
| Burrage Capital Management LLC | 161,628 | $2,822,000 | 2.15% |
| AIGH Capital Management LLC | 274,583 | $4,794,000 | 1.95% |
| NEA Management Company, LLC | 4,187,801 | $73,119,000 | 1.93% |
| Novo Holdings A/S | 2,445,147 | $42,692,000 | 1.83% |
| Sio Capital Management, LLC | 494,743 | $8,638,000 | 1.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,448,912 | $60,218,000 | 1.19% |
| Rock Springs Capital Management LP | 1,496,525 | $26,129,000 | 0.55% |
| Prosight Management, LP | 60,250 | $1,052,000 | 0.49% |